SINGLE-DOSE MEDICATIONS FOR THE TREATMENT OR PREVENTION OF HYPERTENSION AND HYPERLIPIDEMIA
VN10062152BActive Publication Date: 2026-11-02DAEWOONG PHARM CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- VN1202301047
- Authority / Receiving Office
- VN · VN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-08-25
- Publication Date
- 2026-11-02
- Estimated Expiration
- 2041-08-25
Abstract
The invention proposes a single-dose formulation of a pharmaceutical for the treatment of hypertension and hyperlipidemia. According to the formulation, the stability and uniform dissolution rate of the drug can be ensured by mixing the components containing the desired drug and formulating the mixture into a single-compartment formulation, thereby simplifying the manufacturing process and reducing production costs. Furthermore, a bioequivalent pharmaceutical preparation can be obtained from conventional single-dose formulations.
Need to check novelty before this filing date? Find Prior Art
